Literature DB >> 18481003

Up-regulation of human leukocyte antigen G expression in primary cutaneous malignant melanoma associated with host-vs-tumor immune response.

Xianfeng Fang1, Xuxin Zhang, Jiawen Li.   

Abstract

Human leukocyte antigen G (HLA-G) is one of the molecules implicated in immunotolerance. To investigate the role of HLA-G in primary cutaneous malignant melanoma (CMM), a series of 47 skin melanocytic lesions were immunohistochemically evaluated. The correlation between HLA-G expression and CMM clinicohistopathological data and Bcl-2 expression was also analyzed. HLA-G expression was detected in a variety of cell types. No significant difference in HLA-G expression was observed between malignant and non-malignant melanocytic lesions. HLA-G expression was significantly correlated with the inflammatory infiltration and Bcl-2 expression, whereas no significant correlation with ulceration, tumor thickness, clinical stage, histopathological subtypes were observed. HLA-G expression may be the result of host immune reaction in tumor microenvironment rather than a malignant feature of CMM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481003     DOI: 10.1007/s11596-008-0227-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

Review 1.  Biology and functions of human leukocyte antigen-G in health and sickness.

Authors:  J LeMaoult; M Le Discorde; N Rouas-Freiss; P Moreau; C Menier; J McCluskey; E D Carosella
Journal:  Tissue Antigens       Date:  2003-10

2.  HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

Authors:  Nathalie Rouas-Freiss; Philippe Moreau; Soldano Ferrone; Edgardo D Carosella
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

Review 3.  Update of diagnostic and prognostic markers in cutaneous malignant melanoma.

Authors:  J A Reed; A P Albino
Journal:  Clin Lab Med       Date:  2000-12       Impact factor: 1.935

4.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

Authors:  P Paul; N Rouas-Freiss; I Khalil-Daher; P Moreau; B Riteau; F A Le Gal; M F Avril; J Dausset; J G Guillet; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

Authors:  El Chérif Ibrahim; Sélim Aractingi; Yves Allory; Francesco Borrini; Alain Dupuy; Pierre Duvillard; Edgardo D Carosella; Marie Françoise Avril; Pascale Paul
Journal:  Int J Cancer       Date:  2004-01-10       Impact factor: 7.396

Review 6.  The tumor microenvironment: a critical determinant of neoplastic evolution.

Authors:  Léon C L T van Kempen; Dirk J Ruiter; Goos N P van Muijen; Lisa M Coussens
Journal:  Eur J Cell Biol       Date:  2003-11       Impact factor: 4.492

  6 in total
  3 in total

Review 1.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

2.  Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.

Authors:  Tiefu Chen; Jie Zhu
Journal:  Med Oncol       Date:  2009-11-17       Impact factor: 3.064

Review 3.  The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.

Authors:  Fabrício C Dias; Erick C Castelli; Cristhianna V A Collares; Philippe Moreau; Eduardo A Donadi
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.